Bone Short Long Term Debt vs Cash Analysis
| BBLG Stock | USD 1.88 0.32 14.55% |
Bone Biologics financial indicator trend analysis is way more than just evaluating Bone Biologics Corp prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bone Biologics Corp is a good investment. Please check the relationship between Bone Biologics Short Long Term Debt and its Cash accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bone Biologics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Short Long Term Debt vs Cash
Short Long Term Debt vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bone Biologics Corp Short Long Term Debt account and Cash. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Bone Biologics' Short Long Term Debt and Cash is 0.44. Overlapping area represents the amount of variation of Short Long Term Debt that can explain the historical movement of Cash in the same time period over historical financial statements of Bone Biologics Corp, assuming nothing else is changed. The correlation between historical values of Bone Biologics' Short Long Term Debt and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Long Term Debt of Bone Biologics Corp are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Short Long Term Debt i.e., Bone Biologics' Short Long Term Debt and Cash go up and down completely randomly.
Correlation Coefficient | 0.44 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Short Long Term Debt
The total of a company’s short-term and long-term borrowings.Cash
Cash refers to the most liquid asset of Bone Biologics Corp, which is listed under current asset account on Bone Biologics Corp balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Bone Biologics customers. The amounts must be unrestricted with restricted cash listed in a different Bone Biologics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.Most indicators from Bone Biologics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bone Biologics Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bone Biologics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, Bone Biologics' Enterprise Value Over EBITDA is most likely to increase significantly in the upcoming years. The Bone Biologics' current Enterprise Value Multiple is estimated to increase to 0.20, while Selling General Administrative is projected to decrease to roughly 2 M.
Bone Biologics fundamental ratios Correlations
Click cells to compare fundamentals
Bone Biologics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bone Biologics fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Common Stock Shares Outstanding | 12.2K | 12.1K | 18.9K | 47.6K | 263.1K | 250.0K | |
| Total Assets | 30.8K | 0.0 | 6.7M | 8.5M | 3.7M | 2.3M | |
| Net Debt | 11.3M | 11.7M | (6.7M) | (7.5M) | (3.0M) | (2.9M) | |
| Cash | 24.1K | 0.0 | 6.7M | 7.5M | 3.0M | 2.0M | |
| Cash And Short Term Investments | 955.4K | 24.1K | 6.7M | 7.5M | 3.0M | 2.1M | |
| Liabilities And Stockholders Equity | 1.0M | 30.8K | 6.7M | 8.5M | 3.7M | 2.5M | |
| Total Current Assets | 30.8K | 0.0 | 6.7M | 8.5M | 3.7M | 2.3M | |
| Other Current Liab | 513.7K | 535.6K | 1.5M | 2.5M | 470.7K | 447.2K | |
| Total Current Liabilities | 578.4K | 13.7M | 99.9K | 2.5M | 831.4K | 789.8K | |
| Total Stockholder Equity | (11.9M) | (13.7M) | 6.6M | 5.9M | 2.9M | 3.1M | |
| Retained Earnings | (67.0M) | (68.9M) | (70.5M) | (72.0M) | (80.9M) | (76.9M) | |
| Total Liab | 11.9M | 13.7M | 99.9K | 2.5M | 831.4K | 789.8K | |
| Short Long Term Debt Total | 8.2M | 9M | 11.3M | 11.7M | 13.5M | 8.3M | |
| Other Current Assets | 105.2K | 85.3K | 6.7K | 956.9K | 711.2K | 746.8K | |
| Net Tangible Assets | (8.6M) | (11.9M) | (13.7M) | 6.6M | 7.6M | 7.9M | |
| Accounts Payable | 42.9K | 465.4K | 99.9K | 888.46 | 360.7K | 202.9K | |
| Non Current Liabilities Total | 8.2M | 0.0 | 11.3M | 12.2M | 99.9K | 888.46 | |
| Net Invested Capital | (547.6K) | (2.0M) | 6.6M | 5.9M | 2.9M | 2.1M | |
| Net Working Capital | (547.6K) | (13.7M) | 6.6M | 5.9M | 2.9M | 3.1M |
Currently Active Assets on Macroaxis
When determining whether Bone Biologics Corp is a strong investment it is important to analyze Bone Biologics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bone Biologics' future performance. For an informed investment choice regarding Bone Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bone Biologics Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Bone Stock analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Bone Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bone Biologics. If investors know Bone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bone Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (34.01) | Return On Assets (0.85) | Return On Equity (1.89) |
The market value of Bone Biologics Corp is measured differently than its book value, which is the value of Bone that is recorded on the company's balance sheet. Investors also form their own opinion of Bone Biologics' value that differs from its market value or its book value, called intrinsic value, which is Bone Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bone Biologics' market value can be influenced by many factors that don't directly affect Bone Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bone Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bone Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bone Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.